Brägelmann, Johannes <br/><br/>
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.  [electronic resource] 

 -  Cell reports  Sep 2017 
 - 2833-2845 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2211-1247 
<br/><br/><label>Standard No.: </label>10.1016/j.celrep.2017.08.082  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Cycle Proteins<br/>Cell Line, Tumor<br/>Cyclin T--metabolism<br/>Cyclin-Dependent Kinase 9--antagonists & inhibitors<br/>HEK293 Cells<br/>High-Throughput Screening Assays<br/>Humans<br/>Molecular Targeted Therapy<br/>Neoplasms--enzymology<br/>Nuclear Proteins--antagonists & inhibitors<br/>Protein Kinase Inhibitors--chemistry<br/>RNA Polymerase II--metabolism<br/>Transcription Elongation, Genetic--drug effects<br/>Transcription Factors--antagonists & inhibitors<br/>Transcription, Genetic--drug effects